Literature DB >> 11130109

Adductor spasmodic dysphonia and muscular tension dysphonia: acoustic analysis of sustained phonation and reading.

C M Sapienza1, S Walton, T Murry.   

Abstract

Acoustic phonatory events were identified in 10 women diagnosed with adductor spasmodic dysphonia (ADSD) and compared to 5 women and 5 men diagnosed with muscle tension dysphonia (MTD). The three acoustic parameters examined during sustained vowel production and reading included phonatory breaks, aperiodicity, and frequency shifts. Intra- and intermeasurer correlations showed high reliability for the measures. Findings indicated that those with ADSD produced a greater number of aberrant acoustic events than those with MTD. The results suggested that: (1) only those with ADSD show evidence of phonatory breaks during vocalization, albeit a sustained vowel or voicing during reading; (2) those with ADSD demonstrate greater variation in the type of aberrant acoustic events produced as a function of speech task. The latter point suggests that control of the larynx varies as a function of task demand, a finding not evident in the functionally based disorder of MTD. MTD is a disorder that often presents itself in a similar clinical manner to ADSD because of its perceptual commonalties and resembling laryngoscopic characteristics. The acoustic analysis presented in this study could be used as a method to assist in distinguishing between the two disorder types.

Entities:  

Mesh:

Year:  2000        PMID: 11130109     DOI: 10.1016/s0892-1997(00)80008-9

Source DB:  PubMed          Journal:  J Voice        ISSN: 0892-1997            Impact factor:   2.009


  8 in total

1.  Acoustic Model of Perceived Overall Severity of Dysphonia in Adductor-Type Laryngeal Dystonia.

Authors:  Daniel P Buckley; Manuel Diaz Cadiz; Tanya L Eadie; Cara E Stepp
Journal:  J Speech Lang Hear Res       Date:  2020-07-16       Impact factor: 2.297

2.  Abnormal activation of the primary somatosensory cortex in spasmodic dysphonia: an fMRI study.

Authors:  Kristina Simonyan; Christy L Ludlow
Journal:  Cereb Cortex       Date:  2010-03-01       Impact factor: 5.357

3.  Cortical Silent Period Reveals Differences Between Adductor Spasmodic Dysphonia and Muscle Tension Dysphonia.

Authors:  Sharyl Samargia; Rebekah Schmidt; Teresa Jacobson Kimberley
Journal:  Neurorehabil Neural Repair       Date:  2015-06-18       Impact factor: 3.919

Review 4.  Research priorities in spasmodic dysphonia.

Authors:  Christy L Ludlow; Charles H Adler; Gerald S Berke; Steven A Bielamowicz; Andrew Blitzer; Susan B Bressman; Mark Hallett; H A Jinnah; Uwe Juergens; Sandra B Martin; Joel S Perlmutter; Christine Sapienza; Andrew Singleton; Caroline M Tanner; Gayle E Woodson
Journal:  Otolaryngol Head Neck Surg       Date:  2008-10       Impact factor: 3.497

5.  Focal white matter changes in spasmodic dysphonia: a combined diffusion tensor imaging and neuropathological study.

Authors:  Kristina Simonyan; Fernanda Tovar-Moll; John Ostuni; Mark Hallett; Victor F Kalasinsky; Michael R Lewin-Smith; Elisabeth J Rushing; Alexander O Vortmeyer; Christy L Ludlow
Journal:  Brain       Date:  2007-12-14       Impact factor: 13.501

Review 6.  Speech-Language Pathology Evaluation and Management of Hyperkinetic Disorders Affecting Speech and Swallowing Function.

Authors:  Julie M Barkmeier-Kraemer; Heather M Clark
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2017-09-21

7.  Injection laryngoplasty as adjunct treatment method for muscle tension dysphonia: Preliminary findings.

Authors:  Daniel Novakovic; Duong Duy Nguyen; Antonia Chacon; Catherine Madill
Journal:  Laryngoscope       Date:  2019-07-30       Impact factor: 3.325

8.  Effects of low-frequency repetitive transcranial magnetic stimulation in adductor laryngeal dystonia: a safety, feasibility, and pilot study.

Authors:  Cecília N Prudente; Mo Chen; Kaila L Stipancic; Katherine L Marks; Sharyl Samargia-Grivette; George S Goding; Jordan R Green; Teresa J Kimberley
Journal:  Exp Brain Res       Date:  2021-12-02       Impact factor: 1.972

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.